To kick start Sarcoma Awareness Week 2015, we invited you to join us at our exciting event, Talking Research. Over 130 of you attended our event in Manchester, thank you for all of your support.
Together with people from across the sarcoma community, we heard from ground-breaking sarcoma researchers, as well as inspiring speakers such as our trustee, Dave Thompson, and patron, Richard Whitehead. It was pleasure to meet so many people interested in sarcoma research, and the projects funded by Sarcoma UK and our supporters. We hope you all had a fantastic time, we’ll be sharing pictures in the near future. Thank you to everyone who made it, and to all our supporters who have helped us fund our world-class research programme.
View pictures from the day
Through the generous donations of our supporters, this year Sarcoma UK will have awarded over £1million in research grants. Talking Research is a unique opportunity to meet world class sarcoma researchers whose work is supported by these grants.
Date: Saturday 13 June 2015
Venue: The Palace Hotel, Manchester M60 7HA
Come along to hear sarcoma researchers talking about why they became interested in sarcoma research, how their projects benefit sarcoma patients throughout the UK, and offering insights into the future of sarcoma research.
A highlight of the event is a guest appearance from Sarcoma UK’s Patron, Paralympic gold medallist, Richard Whitehead MBE. Richard will talk about his support for Sarcoma UK, and his extraordinary 40 marathons in 40 days challenge.
You will also have the chance to meet other people affected by sarcoma in a relaxed, social environment over lunch and at an informal reception to the end of the day.
The event is free, but we do ask that you register in advance.
For more information about the venue and transport, please don’t hesitate to contact our team, who will be happy to help: email@example.com
We look forward to seeing you there!
This event is supported by an unrestricted educational grant from PharmaMar
The Talking Research conference is supported by a financial grant from Takeda UK Ltd. Takeda has had no involvement in speaker selection or meeting content
Supported by a grant from Novartis